Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer

Ferroptosis, a form of programed cell death, can be promoted by inhibitors of the xCT transporter (erastin) or GPX4 (RSL3). We found that GPX4, but not the xCT transporter, is selectively elevated in luminal breast cancer. Consistent with this observation, the majority of luminal breast cancer cell...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cell death & disease Ročník 14; číslo 8; s. 532 - 12
Hlavní autoři:	Park, Soon Young, Jeong, Kang Jin, Poire, Alfonso, Zhang, Dong, Tsang, Yiu Huen, Blucher, Aurora S., Mills, Gordon B.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 18.08.2023 Springer Nature B.V Nature Publishing Group
Témata:	13/1 13/106 13/2 13/31 13/89 14/19 14/34 14/63 38/79 42/41 45/47 631/154/555 631/80/82 64/60 96/2 Antibodies Apoptosis Biochemistry Biomedical and Life Sciences Breast cancer Cancer therapies Cell Biology Cell Culture Cell death Clinical trials DNA damage Enzymes ErbB-2 protein Ferroptosis Humans Immunology Iron Life Sciences Lipid Peroxidation Lipids MCF-7 Cells Membrane Transport Proteins Neoplasms Phosphorylation Proteins Reactive oxygen species S phase Tumor cell lines
ISSN:	2041-4889, 2041-4889
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!